INVIVO CORP
10-K, EX-23.01, 2000-09-26
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: INVIVO CORP, 10-K, EX-21.01, 2000-09-26
Next: INVIVO CORP, 10-K, EX-27.01, 2000-09-26



<PAGE>   1

                                                                   EXHIBIT 23.01

                         CONSENT OF INDEPENDENT AUDITORS

                    INDEPENDENT AUDITORS' REPORT AND CONSENT


The Board of Directors and Stockholders
Invivo Corporation:

Under date of July 28, 2000, we reported on the consolidated balance sheets of
Invivo Corporation and subsidiaries (the Company) as of June 30, 2000 and 1999,
and the related consolidated statements of income, changes in stockholders'
equity and comprehensive income, and cash flows for each of the years in the
three-year period ended June 30, 2000, which are included in Form 10K. In
connection with our audits of the aforementioned consolidated financial
statements, we also audited the related consolidated financial statement
schedule, Valuation and Qualifying Accounts, in Form 10K. This financial
statement schedule is the responsibility of the Company's management. Our
responsibility is to express an opinion on this financial statement schedule
based on our audits. In our opinion, such financial statement schedule, when
considered in relation to the consolidated financial statements taken as a
whole, presents fairly, in all material respects, the information set forth
therein.

We consent to incorporation by reference in the registration statements (Nos.
33-32749 and 33-68831) on Form S-8 of Invivo Corporation and subsidiaries of
our reports relating to the consolidated balance sheets of Invivo Corporation
as of June 30, 2000 and 1999, and the related consolidated statements of
income, changes in stockholders' equity and cash flows for each of the years in
the three-year period ended June 30, 2000, and related schedule, which reports
appear in the June 30, 2000 annual report on Form 10K of Invivo Corporation.



San Francisco, California
September 25, 2000







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission